Loss of heterozygosity and methylation of p16 in renal cell carcinoma

被引:24
|
作者
Sanz-Casla, MT
Maestro, ML
del Barco, V
Zanna, I
Moreno, J
Vidaurreta, M
Almansa, I
Fernández, C
Blanco, J
Maestro, C [1 ]
Resel, L
机构
[1] Hosp Clin San Carlos, Lab, Dept Tumor Biol, Madrid 28040, Spain
[2] Hosp Clin San Carlos, Dept Urol, Madrid 28040, Spain
[3] Hosp Clin San Carlos, Dept Pathol, Madrid 28040, Spain
[4] Hosp Clin San Carlos, Dept Epidemiol, Madrid 28040, Spain
[5] Univ Complutense, Dept Mophol Sci, E-28040 Madrid, Spain
来源
UROLOGICAL RESEARCH | 2003年 / 31卷 / 03期
关键词
loss of heterozygosity; methylation; p16; gene; renal cell carcinoma;
D O I
10.1007/s00240-003-0308-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To investigate the possible role of genomic aberrations of chromosome 9p21 in the tumorigenesis of human renal cell carcinoma (RCC), 40 sporadic RCCs were studied using PCR analyses. The tumours were predominantly low stage and low grade. Loss of heterozygosity (LOH) was observed in nine of 39 informative cases, but no homozygous deletion was noticed. Hypermethylation of the promoter region of p16 occurred in eight of the 40 RCCs. No correlation was found between hypermethylation of the p16 gene and LOH on 9p21. A similar level of LOH and methylation was observed in the 40 RCCS regardless of histology, grade and stage. These results suggest that inactivation of p16 and the possibility of other unknown tumour suppresser genes located on other chromosomes could be involved in the pathogenesis of RCC.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [41] Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa
    ZHANG Jing
    LAI Mao-De and CHEN Jian(Department of Clinical Pathology
    [J]. World Journal of Gastroenterology, 1999, (05) : 451 - 454
  • [42] INFREQUENT INVOLVEMENT OF P(53) MUTATIONS AND LOSS OF HETEROZYGOSITY OF 17P IN THE TUMORIGENESIS OF RENAL-CELL CARCINOMA
    UCHIDA, T
    WADA, C
    SHITARA, T
    EGAWA, S
    MASHIMO, S
    KOSHIBA, K
    [J]. JOURNAL OF UROLOGY, 1993, 150 (04): : 1298 - 1301
  • [43] Mutation of the p16/CDKN2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck
    Suzuki, Norihisa
    Onda, Takeshi
    Yamamoto, Nobuharu
    Katakura, Akira
    Mizoe, Jun-Etsu
    Shibahara, Takahiko
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (05) : 1061 - 1067
  • [44] Methylation of p16 gene in hematological malignancies
    Chen, WM
    Zhu, JZ
    Liu, JZ
    Tan, SZ
    [J]. CHINESE MEDICAL JOURNAL, 1998, 111 (11) : 1028 - 1030
  • [45] Methylation of p16 gene in hematological malignancies
    陈文明
    朱嘉芷
    刘敬忠
    潭淑珍
    [J]. 中华医学杂志(英文版), 1998, (11) : 69 - 71
  • [46] Methylation of p16 gene in hematological malignancies
    陈文明
    朱嘉芷
    刘敬忠
    潭淑珍
    [J]. Chinese Medical Journal., 1998, (11)
  • [47] 5′ CpG island methylation of p16 is associated with absence of p16 expression in glioblastomas
    Park, SH
    Jung, KC
    Ro, JY
    Kang, GH
    Khang, SK
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (05) : 555 - 559
  • [48] Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study
    Fan, Zhiyuan
    Qin, Yu
    Zhou, Jing
    Chen, Ru
    Gu, Jianhua
    Li, Minjuan
    Zhou, Jiachen
    Li, Xinqing
    Lin, Dongmei
    Wang, Jinwu
    Deng, Dajun
    Wei, Wenqiang
    [J]. CANCER MEDICINE, 2022, 11 (21): : 4033 - 4042
  • [49] P16 Expression in Small Cell Carcinoma of the Urinary Bladder
    Buza, N.
    Finkelstein, A.
    Hui, P.
    Cohen, P.
    Parkash, V.
    [J]. MODERN PATHOLOGY, 2009, 22 : 161A - 161A
  • [50] p16 Not a Prognostic Marker for Hypopharyngeal Squamous Cell Carcinoma
    Wilson, David D.
    Rahimi, Asal S.
    Saylor, Drew K.
    Stelow, Edward B.
    Jameson, Mark J.
    Shonka, David C., Jr.
    Reibel, James F.
    Levine, Paul A.
    Read, Paul W.
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 138 (06) : 556 - 561